NASDAQ NMS - GLOBAL MARKET · AEON
+1.10% · $0.0000 · Vol Not reported
Pre-market · updated 04:36:00 ET
AEON Biopharma Inc

AEON Biopharma Inc

N/A
$0.3134
Card
Relationship Map

Follow $AEON

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AEON by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
AEON
AEON Biopharma Inc
Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

53/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AEON moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AEON catalysts
About AEON Biopharma Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
8
Country
US

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3100
Last session
Day high
$0.3100
Last session
Day low
$0.3100
Last session
Previous close
$0.3100
52W high
$1.40
-77.61% from high
52W low
$0.1921
10% of range
Market cap
$15.5M
EPS
$-3.5840
Beta
0.77
Shares out
49.9M
Avg volume
13.2M
VWAP
$0.3100
Last session
Price history computed in-house
1W
+12.33%
1M
+35.67%
3M
-35.13%
1Y
-69.57%
YTD
-71.51%
SMA 50 $0.2661 · above
SMA 200 $0.7446 · below
52W position 10%

AEON overview

Veridion Score
53
Registered · 2026-10-08
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AEON.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AEON Form 4 filings
Public disclosures

Congress activity in AEON

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

AEON contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AEON in this window.
Lobbying spend

AEON lobbying filings, year to date.

Registered lobbying filings matched to AEON Biopharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AEON in this window.
Loading news for AEON
Analyst ratings
Sovereign unlock shows live analyst consensus for AEON.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.